Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Pain Regimen in Orthopaedic Trauma Patients
NCT02160301Phase 4Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin, celecoxib oral solution, dexamethasone, acetaminophen in postoperative pain, sponsored by University of North Carolina at Chapel Hill. Planned start Nov 2017; status: withdrawn.
02
Drugs
gabapentincelecoxib oral solutiondexamethasoneacetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02160301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160301.